DK3204398T3 - Fremgangsmåder til fraseparering af gemcitabin-phosphat diastereoisomerer - Google Patents
Fremgangsmåder til fraseparering af gemcitabin-phosphat diastereoisomerer Download PDFInfo
- Publication number
- DK3204398T3 DK3204398T3 DK15782005.1T DK15782005T DK3204398T3 DK 3204398 T3 DK3204398 T3 DK 3204398T3 DK 15782005 T DK15782005 T DK 15782005T DK 3204398 T3 DK3204398 T3 DK 3204398T3
- Authority
- DK
- Denmark
- Prior art keywords
- gemcitabin
- procedures
- pharmaceutical preparation
- diastereoisomer
- phosphate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
- C07H1/06—Separation; Purification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1417644.0A GB201417644D0 (en) | 2014-10-06 | 2014-10-06 | Method of separating phosphate diastereoisomers |
| PCT/GB2015/052839 WO2016055769A1 (en) | 2014-10-06 | 2015-09-29 | Methods of separating gemcitabine-phosphate diastereoisomers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3204398T3 true DK3204398T3 (da) | 2020-06-02 |
Family
ID=51946917
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK15782005.1T DK3204398T3 (da) | 2014-10-06 | 2015-09-29 | Fremgangsmåder til fraseparering af gemcitabin-phosphat diastereoisomerer |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US10669300B2 (da) |
| EP (2) | EP3204398B1 (da) |
| JP (2) | JP6893172B2 (da) |
| KR (1) | KR102532498B1 (da) |
| CN (2) | CN112552362A (da) |
| AU (2) | AU2015329767B2 (da) |
| CA (1) | CA2959977C (da) |
| CL (1) | CL2017000819A1 (da) |
| CY (1) | CY1123061T1 (da) |
| DK (1) | DK3204398T3 (da) |
| EA (1) | EA033118B1 (da) |
| ES (1) | ES2793957T3 (da) |
| GB (1) | GB201417644D0 (da) |
| HR (1) | HRP20200849T1 (da) |
| HU (1) | HUE050882T2 (da) |
| IL (1) | IL251125B (da) |
| LT (1) | LT3204398T (da) |
| MA (1) | MA41039B1 (da) |
| ME (1) | ME03730B (da) |
| MX (2) | MX2017004446A (da) |
| MY (1) | MY183302A (da) |
| PH (1) | PH12017500586A1 (da) |
| PL (1) | PL3204398T3 (da) |
| PT (1) | PT3204398T (da) |
| RS (1) | RS60634B1 (da) |
| SG (2) | SG11201701885UA (da) |
| SI (1) | SI3204398T1 (da) |
| WO (1) | WO2016055769A1 (da) |
| ZA (1) | ZA201701723B (da) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0317009D0 (en) * | 2003-07-21 | 2003-08-27 | Univ Cardiff | Chemical compounds |
| SG11201503750YA (en) | 2012-11-16 | 2015-06-29 | Univ Cardiff | Process for preparing nucleoside prodrugs |
| SG11201608809RA (en) | 2014-06-25 | 2016-11-29 | Nucana Biomed Ltd | Formulation comprising a gemcitabine-prodrug |
| SI3160978T1 (sl) | 2014-06-25 | 2020-11-30 | NuCana plc | Gemcitabin predzdravila |
| GB201417644D0 (en) | 2014-10-06 | 2014-11-19 | Nucana Biomed Ltd | Method of separating phosphate diastereoisomers |
| CN106543220A (zh) | 2015-09-16 | 2017-03-29 | 博瑞生物医药（苏州）股份有限公司 | 氨基磷酸酯化合物及其制备方法和晶体 |
| CN106539810B (zh) | 2015-09-16 | 2021-03-09 | 济南高合医疗科技有限公司 | 一种富集了nuc-1031单一异构体的组合物及其制备方法和用途 |
| CN106543252A (zh) | 2015-09-16 | 2017-03-29 | 博瑞生物医药（苏州）股份有限公司 | 核苷氨基磷酸酯类前药的制备方法及其中间体 |
| KR20180063075A (ko) | 2015-10-05 | 2018-06-11 | 뉴카나 피엘씨 | 조합 요법 |
| EP4011896A1 (en) | 2015-12-11 | 2022-06-15 | NuCana plc | Diastereoselective synthesis of (sp)-gemcitabine-[phenyl(benzoxy-l-alaninyl)]phosphate nuc-1031 |
| GB201522771D0 (en) * | 2015-12-23 | 2016-02-03 | Nucana Biomed Ltd | Crystalline form of a phosphate derivative |
| CN107652342A (zh) * | 2016-07-23 | 2018-02-02 | 江苏万高药业股份有限公司 | 核苷氨基磷酸酯类前药的多晶型及其制备方法 |
| GB201709471D0 (en) | 2017-06-14 | 2017-07-26 | Nucana Biomed Ltd | Diastereoselective synthesis of hosphate derivatives |
| CN107400156B (zh) * | 2017-09-19 | 2020-01-31 | 北京大学 | 一种分离麦角甾烷型三萜25r-与25s-差向异构体的方法 |
| CN115028594A (zh) * | 2020-06-03 | 2022-09-09 | 吴卫东 | 恩替他滨药用前体化合物及其制备方法和医学用途 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1254092T3 (da) * | 2000-02-11 | 2004-03-15 | Degussa | Resolvering af DL-racemiske blandinger |
| GB0317009D0 (en) * | 2003-07-21 | 2003-08-27 | Univ Cardiff | Chemical compounds |
| FR2954310B1 (fr) * | 2009-12-18 | 2014-07-25 | Univ Rouen | Procede de dedoublement d'enantiomeres par evapocristallisation preferentielle |
| SG11201503750YA (en) | 2012-11-16 | 2015-06-29 | Univ Cardiff | Process for preparing nucleoside prodrugs |
| WO2014204856A1 (en) | 2013-06-17 | 2014-12-24 | Catabasis Pharmaceuticals, Inc. | Fatty acid anticancer derivatives and their uses |
| WO2015081133A2 (en) | 2013-11-27 | 2015-06-04 | Idenix Pharmaceuticals, Inc. | Nucleotides for the treatment of liver cancer |
| SG11201608809RA (en) * | 2014-06-25 | 2016-11-29 | Nucana Biomed Ltd | Formulation comprising a gemcitabine-prodrug |
| SI3160978T1 (sl) | 2014-06-25 | 2020-11-30 | NuCana plc | Gemcitabin predzdravila |
| US9834577B2 (en) | 2014-07-22 | 2017-12-05 | Laurus Labs Limited | Process for the preparation of gemcitabine-[phenyl(benzoxy-L-alaninyl)] phosphate |
| GB201417644D0 (en) | 2014-10-06 | 2014-11-19 | Nucana Biomed Ltd | Method of separating phosphate diastereoisomers |
| TR201806642T4 (tr) | 2015-05-14 | 2018-06-21 | NuCana plc | Kanser tedavileri. |
| KR20180063075A (ko) | 2015-10-05 | 2018-06-11 | 뉴카나 피엘씨 | 조합 요법 |
| EP4011896A1 (en) | 2015-12-11 | 2022-06-15 | NuCana plc | Diastereoselective synthesis of (sp)-gemcitabine-[phenyl(benzoxy-l-alaninyl)]phosphate nuc-1031 |
| CA3008749C (en) | 2015-12-23 | 2024-01-02 | NuCana plc | Treatment of ovarian cancer or biliary tract cancer with a combination of gemcitabine-(phenyl-benzoxy-l-alaninyl)]-phosphate and cisplatin |
| AU2015418015B2 (en) | 2015-12-23 | 2021-12-09 | NuCana plc | Combination therapy |
| GB201522771D0 (en) | 2015-12-23 | 2016-02-03 | Nucana Biomed Ltd | Crystalline form of a phosphate derivative |
-
2014
- 2014-10-06 GB GBGB1417644.0A patent/GB201417644D0/en not_active Ceased
-
2015
- 2015-09-29 EP EP15782005.1A patent/EP3204398B1/en active Active
- 2015-09-29 MA MA41039A patent/MA41039B1/fr unknown
- 2015-09-29 LT LTEP15782005.1T patent/LT3204398T/lt unknown
- 2015-09-29 MY MYPI2017000434A patent/MY183302A/en unknown
- 2015-09-29 CN CN202011494200.9A patent/CN112552362A/zh active Pending
- 2015-09-29 ES ES15782005T patent/ES2793957T3/es active Active
- 2015-09-29 MX MX2017004446A patent/MX2017004446A/es active IP Right Grant
- 2015-09-29 SG SG11201701885UA patent/SG11201701885UA/en unknown
- 2015-09-29 PL PL15782005T patent/PL3204398T3/pl unknown
- 2015-09-29 EA EA201790794A patent/EA033118B1/ru unknown
- 2015-09-29 JP JP2017518474A patent/JP6893172B2/ja active Active
- 2015-09-29 KR KR1020177012012A patent/KR102532498B1/ko active IP Right Grant
- 2015-09-29 PT PT157820051T patent/PT3204398T/pt unknown
- 2015-09-29 CA CA2959977A patent/CA2959977C/en active Active
- 2015-09-29 CN CN201580054225.8A patent/CN107108682B/zh active Active
- 2015-09-29 MX MX2020003758A patent/MX2020003758A/es unknown
- 2015-09-29 ME MEP-2020-104A patent/ME03730B/me unknown
- 2015-09-29 SI SI201531226T patent/SI3204398T1/sl unknown
- 2015-09-29 WO PCT/GB2015/052839 patent/WO2016055769A1/en active Application Filing
- 2015-09-29 SG SG10201902952SA patent/SG10201902952SA/en unknown
- 2015-09-29 AU AU2015329767A patent/AU2015329767B2/en active Active
- 2015-09-29 US US15/514,673 patent/US10669300B2/en active Active
- 2015-09-29 RS RS20200611A patent/RS60634B1/sr unknown
- 2015-09-29 HU HUE15782005A patent/HUE050882T2/hu unknown
- 2015-09-29 EP EP20172701.3A patent/EP3725794A1/en not_active Withdrawn
- 2015-09-29 DK DK15782005.1T patent/DK3204398T3/da active
-
2017
- 2017-03-09 ZA ZA2017/01723A patent/ZA201701723B/en unknown
- 2017-03-13 IL IL251125A patent/IL251125B/en active IP Right Grant
- 2017-03-30 PH PH12017500586A patent/PH12017500586A1/en unknown
- 2017-04-04 CL CL2017000819A patent/CL2017000819A1/es unknown
-
2020
- 2020-04-23 JP JP2020076624A patent/JP6967625B2/ja active Active
- 2020-05-25 CY CY20201100477T patent/CY1123061T1/el unknown
- 2020-05-26 HR HRP20200849TT patent/HRP20200849T1/hr unknown
- 2020-06-05 AU AU2020203714A patent/AU2020203714B2/en not_active Ceased
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3204398T3 (da) | Fremgangsmåder til fraseparering af gemcitabin-phosphat diastereoisomerer | |
| DK3192902T3 (da) | Fremgangsmåde til fremstilling af graphenholdige viscosefibre | |
| DK3096741T3 (da) | Fremgangsmåde til fremstillingen af hybridosomer | |
| DK3212233T3 (da) | Kombinationsterapi til behandling af sygdom | |
| DK3137169T3 (da) | Hæmmere af lysin-specifik demethylase-1 | |
| DK3166976T3 (da) | Anti-pd-l1-kombinationer til behandling af tumorer | |
| DK3236943T3 (da) | Sammensætninger til ileo-jejunal lægemiddeladministration | |
| DK3851537T3 (da) | Behandling af hyperbilirubinæmi | |
| DK3174858T3 (da) | Fremgangsmåde til fremstilling af pyrazoler | |
| DK3244948T3 (da) | Bestemmelse af medikamentdosis | |
| DK3218828T3 (da) | Dataindsamling til dosering af lægemidler | |
| DK3160956T3 (da) | Inhibitorer af lysin-specifik demethylase-1 | |
| DK3180331T3 (da) | Polymorfer af selinexor | |
| DK3481838T3 (da) | Nye fremgangsmåder til fremstillingen af oligonukleotider | |
| DK3240612T3 (da) | Fremgangsmåder til behandling af nethindesygdomme | |
| DK3089741T3 (da) | Farmaceutiske sammensætninger omfattende azd9291 | |
| BR112016026879A2 (pt) | Composição farmacêutica líquida | |
| DK3511319T3 (da) | Hæmmere af lysinspecifik demethylase-1 | |
| DK3390390T3 (da) | Bipyrazolylderivater egnede til behandling af autoimmunsygdomme | |
| DK3233813T3 (da) | Fremgangsmåder til fremstilling af oxathiazin-lignende forbindelser | |
| DK3237045T3 (da) | Indretning til indgivelse af lægemidler | |
| DK3529240T3 (da) | Farmaceutiske forbindelser | |
| DK3280408T3 (da) | Fremgangsmåde til fremstilling af dicycloplatin | |
| DK3199161T3 (da) | Farmaceutisk præparat | |
| DK3145488T3 (da) | Flydende farmaceutiske forbindelse |